Protein-
protein interactions represent an important post-translational mechanism for
endothelial nitric-oxide synthase (eNOS) regulation. We have previously reported that
beta-actin is associated with eNOS
oxygenase domain and that association of eNOS with
beta-actin increases eNOS activity and
nitric oxide (NO) production. In the present study, we found that
beta-actin-induced increase in NO production was accompanied by decrease in
superoxide formation. A synthetic actin-binding sequence (ABS)
peptide 326 with amino acid sequence corresponding to residues 326-333 of human eNOS, one of the putative ABSs, specifically bound to
beta-actin and prevented eNOS association with
beta-actin in vitro.
Peptide 326 also prevented
beta-actin-induced decrease in
superoxide formation and increase in NO and L-
citrulline production. A modified
peptide 326 replacing hydrophobic
amino acids leucine and
tryptophan with neutral
alanine was unable to interfere with eNOS-
beta-actin binding and to prevent
beta-actin-induced changes in NO and
superoxide formation. Site-directed mutagenesis of the actin-binding domain of eNOS replacing
leucine and
tryptophan with
alanine yielded an eNOS mutant that exhibited reduced eNOS-
beta-actin association, decreased NO production, and increased
superoxide formation in COS-7 cells. Disruption of eNOS-
beta-actin interaction in endothelial cells using ABS
peptide 326 resulted in decreased NO production, increased
superoxide formation, and decreased endothelial monolayer
wound repair, which was prevented by
PEG-SOD and NO donor
NOC-18. Taken together, this novel finding indicates that
beta-actin binding to eNOS through residues 326-333 in the eNOS
protein results in shifting the enzymatic activity from
superoxide formation toward NO production. Modulation of NO and
superoxide formation from eNOS by
beta-actin plays an important role in endothelial function.